The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Pituitary cancer develops in the gland located at the base of the brain called pituitary gland. Pituitary gland secretes hormones that control important body functions. Common symptoms of pituitary cancer include abnormal menstrual cycles, decreased sex drive, vision problems, and headaches. Timely diagnosis and treatment are important to control the progression of pituitary cancer.
Market key trends:
One of the key trends in the pituitary cancer market is increasing number of research studies for developing novel therapeutic drugs and treatment options. This is due to lack of effective treatment options and high unmet need. Currently, standard of care includes surgery, radiation therapy, chemotherapy, and drugs that suppress pituitary hormone secretion. However, these treatments have limited efficacy. Therefore, pharmaceutical companies are focusing on discovery and development of targeted therapies, immunotherapies, and other innovative treatment approaches to effectively treat pituitary cancer and improve patient outcomes.
Segment Analysis
The global pituitary cancer market is segmented based on cancer type, treatment and end use. Based on cancer type, the market is divided into acromegaly, Cushing's disease, ACTH-independent Cushing's syndrome, prolactinomas, thyroid stimulating hormone (TSH)-secreting adenoma and others. Among these, acromegaly dominates the market as it accounts for over 50% of pituitary cancer cases. The high prevalence of acromegaly and its symptoms such as enlargement of hands, feet and face makes it the dominating segment in the market.
Key Takeaways
The global Pituitary Cancer Market Growth is expected to witness high growth, exhibiting CAGR of 9.6% over the forecast period, due to increasing awareness regarding the symptoms and availability of treatment options.
Regional analysis
North America dominates the global pituitary cancer market and accounts for around 40% of the overall market share. The availability of advanced treatment options and increasing healthcare expenditure in the region drives the market growth. Asia Pacific exhibits the fastest growth owing to increasing patient pool in countries like India and China.
Key players
Key players operating in the pituitary cancer market are Novartis International AG, Pfizer Inc., Merck & Co., Inc., Ipsen Biopharmaceuticals, Inc., Bayer AG, Novo Nordisk A/S, Eli Lilly and Company, Bristol Myers Squibb Company, F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Sanofi SA, AstraZeneca PLC, Eisai Co., Ltd., Janssen Pharmaceuticals, Inc. (Johnson & Johnson). The market is highly competitive with the presence of global and domestic players. However, Novartis International AG dominates the market with its wide product portfolio for the treatment of pituitary cancer.
Read More,
https://www.insightprobing.com/pituitary-cancer-market-trends-size-and-share-analysis/
Comments
0 comment